FDA Drug recall D-0046-2015
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Mi…
- FDA Drug
- Class II
- terminated
- Published 2014-11-05
On 2014-11-05 the FDA classified a Class II recall of GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Mi… by Micro Labs Usa S, citing failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0046-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-10-09 |
| Published | 2014-11-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Micro Labs Usa S |
| Distribution | CT, FL, MD, MS, NY |
Product
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540
Reason
Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Identifiers
| ndc | 42571-100-01 |
|---|---|
| ndc | 42571-100-05 |
| ndc | 42571-101-01 |
| ndc | 42571-101-05 |
| ndc | 42571-102-01 |
| ndc | 42571-102-05 |
| ndc | 42571-103-01 |
| ndc | 42571-103-05 |
| ndc | 42571-104-01 |
| ndc | 42571-104-05 |
| ndc | 42571-105-01 |
| ndc | 42571-105-05 |
| code_info | GLBG001 Exp.12/14, GLBG008 Exp. 06/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0046-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.